Chinese Journal of Pharmacovigilance ›› 2013, Vol. 10 ›› Issue (12): 705-708.

    Next Articles

Protectiv e Effect of Total Glucoside of for Injection on Concanavalin A-induced Liver Injury in Mice

WANG Shu-juan1, JIA Zhi-dan2, WEI Huai-ling3, MIAO Lu -yang3, ZHANG Dan3 ,SUN Hua3*   

  1. 1.Institute of Chemical Engineering, Changchun University of Technology, Jilin Changchun 130012, China;
    2.Sinopharm A-Think Pharmaceutical Co.,Ltd, Jilin Changchun 130000, China;
    3.Department of Pharmacology, Institute of Materia Medica, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100050, China
  • Received:2013-10-30 Revised:2016-03-09 Online:2013-12-08 Published:2016-03-09

Abstract: Objective To study the protective effect of total glucoside (TGP) for infection on Concanavalin A(ConA)-induced acute liver injury in ICR mice. Methods ICR mice were given intravenously TGP injection 0.5~8mg·kg-1 for five days(one time/day). After the last administration 2h, the mice were injected intravenously ConA 20mg·kg-1 to establish the immunological liver damage model. All animals were killed on 16h after ConA treatment. The activities of ALT, AST and LDH were measured by automatic chemistry analyzer(TBA-40FR). Liver histopathological changes were examined by H.E. and light microscopy. Results ConA 20mg·kg-1 could induced significant liver damage, expressed in the higher serum ALT,AST,LDH activities and the apoptosis or inflammatory cell infiltration in liver tissue. TGP injection 0.5~4mg·kg-1 showed significantly protective effect to liver damage induced by ConA, which could reduce serum transaminase activities and prevent the pathological injury. The optimum dose is 1mg·kg-1. There wasa reduced efficacy when the dose is 8mg·kg-1. While at this dose, there are no obvious toxicity. Conclusion TGP injection showed a significant protective effect on ConA-induced liver injury in mice. Its effective dose is low and the therapeutic activity will cut down when the dose is higher than 8mg·kg-1. It should be careful to the dose choice in clinical trial.

Key words: total glucosides, injection, Con A, liver injury

CLC Number: